Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome.
暂无分享,去创建一个
T. Nakao | T. Okada | H. Matsumoto | Y. Nagaoka | R. Tomaru | H. Iwasawa | F. Takeguchi
[1] A. Edefonti,et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome , 1993, Pediatric Nephrology.
[2] N. Yoshikawa,et al. Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome , 2001, Pediatric Nephrology.
[3] A. Al-Uzri,et al. Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome , 2001, Pediatric Nephrology.
[4] T. Nakao,et al. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults. , 2001, Clinical Nephrology.
[5] R. Hamed. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. , 1997, JN. Journal of Nephrology (Milano. 1992).
[6] A. Meyrier,et al. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome † , 1994 .
[7] A. Meyrier,et al. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie. , 1994, Kidney International.
[8] B D Kahan,et al. Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability , 1992, Clinical pharmacology and therapeutics.
[9] E. Ingulli,et al. Severe hypercholesterolemia inhibits cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome. , 1992, Journal of the American Society of Nephrology : JASN.
[10] M. Mihatsch,et al. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. , 1992, The New England journal of medicine.
[11] E. Kamil,et al. Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] S. Morita,et al. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] F. Hildebrandt,et al. Cyclosporine A for treatment of nephrotic syndromes. , 1988, Transplantation Proceedings.
[14] E. Lewis,et al. Minimal-change glomerulopathy of adulthood. , 1988, American journal of nephrology.
[15] Z. Varghese,et al. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. , 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] J. Cameron,et al. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. , 1986, Kidney international.
[17] A. Meyrier,et al. Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. , 1986, British medical journal.
[18] A. Edefonti,et al. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. , 1985, British medical journal.
[19] K. L. Wong,et al. Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome. , 1983, Australian and New Zealand journal of medicine.